Not gonna happen. They're in a tough spot, too expensive to buy for the ROI. That Synageva purchase really tanked Alexion for the foreseeable future. You'll see New Haven close in the next 12 months before you'll see a sale. Alexion is positioning itself to focus on M&A rather than developing new products. No need to have that giant waste of money in New Haven to buy products.
That "giant waste of money" houses the people who developed the products that pay all the paychecks. This includes bought products. Current clinical programs and even the one filed for approval cannot proceed without that group (as things stand currently). I hope you are not an employee who is that out of touch with how things work.
If the people who actually matter and earn the money are all located in New Haven then why the move to Boston? Wasn't it under the premise so they could be closer to "a larger talent pool" ? So, they're going to acquire talent in Boston and then have them relocate to New Haven? I guess that makes sense.
If the people who actually matter and earn the money are all located in New Haven then why the move to Boston? Wasn't it under the premise so they could be closer to "a larger talent pool" ? So, they're going to acquire talent in Boston and then have them relocate to New Haven? I guess that makes sense.
If the people who actually matter and earn the money are all located in New Haven then why the move to Boston? Wasn't it under the premise so they could be closer to "a larger talent pool" ? So, they're going to acquire talent in Boston and then have them relocate to New Haven? I guess that makes sense.